The dark side of light: Rhodopsin and the silent death of vision. The Proctor Lecture

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 8, 2005, Pages 2672-2682

  Remé, Charlotte E ^a,b  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; RHODOPSIN;

APOPTOSIS; AUTOPHAGY; CELL DEATH; CELL LOSS; CONFERENCE PAPER; HUMAN; LIGHT DAMAGE; LYSOSOME; MEDICAL EDUCATION; NONHUMAN; PHOTODEGRADATION; PHOTORECEPTOR; PHOTOTRANSDUCTION; PRIORITY JOURNAL; RETINA DEGENERATION; VISUAL IMPAIRMENT; ANIMAL; ARTICLE; AWARDS AND PRIZES; HEALTH CARE ORGANIZATION; HISTORY; LIGHT; OPHTHALMOLOGY; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; RETINA; UNITED STATES; VISUAL DISORDER;

ANIMALS; APOPTOSIS; AWARDS AND PRIZES; FLORIDA; HISTORY, 21ST CENTURY; HUMANS; LIGHT; OPHTHALMOLOGY; RADIATION INJURIES; RETINA; RETINAL DEGENERATION; RHODOPSIN; SOCIETIES, SCIENTIFIC; VISION DISORDERS;

EID: 24644457790     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1095     Document Type: Conference Paper

References (100)

1. Noell WK, Walker VS, Kang BS, Berman S. Retinal damage by light in rats. Invest Ophthalmol. 1966;5:450-473.
2. Remé CE, Hafezi F, Marti A, Munz K, Reinboth JJ. Light damage to retina and pigment epithelium. In: Marmor MF, Wolfensberger TJ, eds. The Retinal Pigment Epithelium:. Function and Disease. New York: Oxford University Press; 1998:568-586.
3. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA. 1994;91:974-978.
4. Remé CE, Grimm C, Hafezi F, Marti A, Wenzel A. Apoptotic cell death in retinal degenerations. Prog Retin Eye Res. 1998;17:443-464.
5. Wenzel A, Grimm C, Remé CE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005;24:275-306.
6. Young RW. Visual cells and the concept of renewal. Invest Ophthalmol Vis Sci. 1976;15:700-725.
7. Szczesny PJ, Munz K, Remé CE. Light damage in the rat retina: patterns of acute lesions and recovery. In: Pleyer U, Thiel HJ, eds. Cell and Tissue Protection in Ophthalmology. Stuttgart, Germany: Hippokrates; 1995;163-175.
8. Eldred GE, Lasky MR. Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature. 1993;361:724-726.
9. Liu J, Itagaki Y, Ben-Shabat S, Nakanishi K, Sparrow JR. The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J Biol Chem. 2000;275:29354-29360.
10. Fishkin N, Jang YP, Itagaki Y, Sparrow JR, Nakanishi K. A2-rhodopsin: a new fluorophore isolated from photoreceptor outer segments. Org Biomol Chem. 2003;1:1101-1105.
11. Redmond TM, Yu S, Lee E, et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998;20:344-351.
12. Grimm C, Wenzel A, Hafezi F, et al. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nat Genet. 2000;25:63-66.
13. Bush RA, Remé CE, Malnoe A. Light damage in the rat retina: the effect of dietary deprivation of N-3 fatty acids on acute structural alterations. Exp Eye Res. 1991;53:741-752.
14. Bush RA, Malnoe A, Remé CE, Williams TP. Dietary deficiency of N-3 fatty acids alters rhodopsin content and function in the rat retina. Invest Ophthalmol Vis Sci. 1994;35:91-100.
15. Remé CE, Malnoe A, Jung HH, Wei Q, Munz K. Effect of dietary fish oil on acute light-induced photoreceptor damage in the rat retina. Invest Ophthalmol Vis Sci. 1994;35:78-90.
16. LaVail MM, Gorrin GM, Repaci MA, Thomas LA, Ginsberg HM. Genetic regulation of light damage to photoreceptors. Invest Ophthalmol Vis Sci. 1987;28:1043-1048.
17. Danciger M, Matthes MT, Yasamura D, et al. A QTL on distal chromosome 3 that influences the severity of light-induced damage to mouse photoreceptors. Mamm Genome. 2000;11:422-427.
18. Wenzel A, Remé CE, Williams TP, Hafezi F, Grimm C. The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration. J Neurosci. 2001;21:53-58.
19. Gollapalli DR, Maiti P, Rando RR. RPE65 operates in the vertebrate visual cycle by stereospecifically binding all-trans-retinyl esters. Biochemistry. 2003;42:11824-11830.
20. Kim SR, Fishkin N, Kong J, et al. Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E. Proc Natl Acad Sci USA. 2004;101:11668-11672.
21. Iseli HP, Wenzel A, Hafezi F, Remé CE, Grimm C. Light damage susceptibility and RPE65 in rats. Exp Eye Res. 2002;75:407-413.
22. Beatrice J, Wenzel A, Remé CE, Grimm C. Increased light damage susceptibility at night does not correlate with RPE65 levels and rhodopsin regeneration in rats. Exp Eye Res. 2003;76:695-700.
23. Penn JS, Anderson RE. Effect of light history on rod outer-segment membrane composition in the rat. Exp Eye Res. 1987;44:767-778.
24. Penn JS, Naash MI, Anderson RE. Effect of light history on retinal antioxidants and light damage susceptibility in the rat. Exp Eye Res. 1987;44:779-788.
25. Organisciak DT, Darrow RM, Barsalou L, Kutty RK, Wiggert B. Circadian-dependent retinal light damage in rats. Invest Ophthalmol Vis Sci. 2000;41:3694-3701.
26. Ishizawa Y, Sharp R, Liebman PA, Eckenhoff RG. Halothane binding to a G protein coupled receptor in retinal membranes by photoaffinity labeling. Biochemistry. 2000;39:8497-8502.
27. Keller C, Grimm C, Wenzel A, Hafezi F, Remé CE. Protective effect of halothane anesthesia on retinal light damage: inhibition of metabolic rhodopsin regeneration. Invest Ophthalmol Vis Sci. 2001;42:476-480.
28. Sieving PA, Chaudhry P, Kondo M, et al. Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci USA. 2001;98:1835-1840.
29. Gollapalli DR, Rando RR. The specific binding of retinoic acid to RPE65 and approaches to the treatment of macular degeneration. Proc Natl Acad Sci USA. 2004;101:10030-10035.
30. Lamb TD, Pugh EN Jr. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res. 2004;23:307-380.
31. Hao W, Wenzel A, Obin MS, et al. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet. 2002; 32:254-260.
32. Morgan JI, Curran T. Immediate-early genes: ten years on. Trends Neurosci. 1995;18:66-67.
33. Smeyne RJ, Vendrell M, Hayward M, et al. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 1993;363:166-169.
34. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131-E136.
35. Nir I, Agarwal N. Diurnal expression of c-fos in the mouse retina. Brain Res Mol Brain Res. 1993;19:47-54.
36. Aronin N, Sagar SM, Sharp FR, Schwartz WJ. Light regulates expression of a Fos-related protein in rat suprachiasmatic nuclei. Proc Natl Acad Sci USA. 1990;87:5959-5962.
37. Rich KA, Zhan Y, Blanks JC. Aberrant expression of c-Fos accompanies photoreceptor cell death in the rd mouse. J Neurobiol. 1997;32:593-612.
38. Hafezi F, Steinbach JP, Marti A, et al. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat Med. 1997;3:346-349.
39. Wenzel A, Iseli HP, Fleischmann A, et al. Fra-1 substitutes for c-Fos in AP-1-mediated signal transduction in retinal apoptosis. J Neurochem. 2002;80:1089-1094.
40. Wenzel A, Grimm C, Samardzija M, Remé CE. The genetic modifier Rpe65Leu(450): effect on light damage susceptibility in c-Fos-deficient mice. Invest Ophthalmol Vis Sci. 2003;44:2798-2802.
41. Fleischmann A, Hafezi F, Flliott C, et al. Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev. 2000;14:2695-2700.
42. Hafezi F, Abegg M, Grimm C, et al. Retinal degeneration in the rd mouse in the absence of c-fos. Invest Ophtbalmol Vis Sci. 1998; 39:2239-2244.
43. Wenzel A, Grimm C, Seeliger MW, et al. Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci. 2001;42:1653-1659.
44. Herrlich P. Cross-talk between glucocorticoid receptor and AP-1. Oncogene. 2001;20:2465-2475.
45. Wenzel A, Grimm C, Marti A, et al. c-fos controls the "private pathway" of light-induced apoptosis of retinal photoreceptors. J Neurosci. 2000;20:81-88.
46. Sperling HG. Spectral sensitivity, intense spectral light studies and the color receptor mosaic of primates. Vision Res. 1986;26:1557-1571.
47. van Norren D, Schellekens P. Blue light hazard in rat. Vision Res. 1990;30:1517-1520.
48. Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:1981-1989.
49. Margrain TH, Boulton M, Marshall J, Sliney DH. Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res. 2004;23:523-531.
50. Grimm C, Remé CE, Rol PO, Williams TP. Blue light's effects on rhodopsin: photoreversal of bleaching in living rat eyes. Invest Ophthalmol Vis Sci. 2000;4l:3984-3990.
51. Grimm C, Wenzel A, Williams T, et al. Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Invest Ophthalmol Vis Sci. 2001;42:497-505.
52. Bartl FJ, Ritter E, Hofmann KP. Signaling states of rhodopsin: absorption of light in active metarhodopsin II generates an alltrans-retinal bound inactive state. J Biol Chem. 2001;276:3016l-30166.
53. Williams TP. Photolysis of metarhodopsin II. Rates of production of P470 and rhodopsin. Vision Res. 1968;8:1457-1466.
54. Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci USA. 2000;97:7154-7159.
55. Suter M, Remé CE, Grimm C, et al. Age-related macular degeneration: the lipofusin component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem. 2000;275:39625-39630.
56. Bergmann M, Schutt F, Holz FG, Kopitz J. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J. 2004;18:562-564.
57. Gaillard ER, Avalle LB, Keller LM, et al. A mechanistic study of the photooxidation of A2E, a component of human retinal lipofuscin. Exp Eye Res. 2004;79:313-319.
58. Friedman J, Xue D. To live or die by the sword: the regulation of apoptosis by the proteasome. Dev Cell. 2004;6:460-461.
59. Johnson DE. Noncaspase proteases in apoptosis. Leukemia. 2000;14:1695-1703.
60. Nagata S. Apoptotic DNA fragmentation. Exp Cell Res. 2000;256:12-18.
61. Schlegel RA, Williamson P. Phosphatidylserine, a death knell. Cell Death Differ. 2001;8:551-563.
62. Wyllie AH, Golstein P. More than one way to go. Proc Natl Acad Sci USA. 2001;98:11-13.
63. Syntichaki P, Tavernarakis N. The biochemistry of neuronal necrosis: rogue biology? Nat Rev Neurosci. 2003;4:672-684.
64. Stoka V, Turk B, Schendel SL, et al. Lysosomal protease pathways to apoptosis: cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem. 2001;276:3149-3157.
65. Guicciardi ME, Leist M, Gores GJ. Lysosomes in cell death. Oncogene. 2004;23:2881-2890.
66. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 2001;8:569-581.
67. Xue L, Fletcher GC, Tolkovsky AM. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci. 1999;14:180-198.
68. Yanagisawa H, Miyashita T, Nakano Y, Yamamoto D. HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death. Cell Death Differ. 2003;10:798-807.
69. Wojcik C. Regulation of apoptosis by the ubiquitin and proteasome pathway. J Cell Mol Med. 2002;6:25-48.
70. Jesenberger V, Jentsch S. Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol. 2002;3:112-121.
71. Abeliovich H, Klionsky DJ. Autophagy in yeast: mechanistic insights and physiological function. Microbiol Mol Biol Rev. 2001; 65:463-479.
72. Mizushima N, Ohsumi Y, Yoshimori T. Autophagosome formation in mammalian cells. Cell Struct Funct. 2002;27:421-429.
73. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717-1721.
74. Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron. 2003;40:401-413.
75. Reme C, Wirz-Justice A, Rhyner A, Hofmann S. Circadian rhythm in the light response of rat retinal disk-shedding and autophagy. Brain Res. 1986;369:356-360.
76. Remé CE, Wolfram U, Imsand C, Hafezi F, Williams TP. Photoreceptor autophagy: effects of light history on number and opsin content of degradative vacuoles. Invest Ophthalmol Vis Sci. 1999;40:2398-2404.
77. Naash MI, Al-Ubaidi MR, Anderson RE. Light exposure induces ubiquitin conjugation and degradation activities in the rat retina. Invest Ophthalmol Vis Sci. 1997;38:2344-2354.
78. Obin M, Lee BY, Meinke G, et al. Ubiquitylation of the transducin betagamma subunit complex: regulation by phosducin. J Biol Chem. 2002;277:44566-44575.
79. Shang F, Taylor A. Function of the ubiquitin proteolytic pathway in the eye. Exp Eye Res. 2004;78:1-14.
80. Louie JL, Kapphahn RJ, Ferrington DA. Proteasome function and protein oxidation in the aged retina. Exp Eye Res. 2002;75:271-284.
81. Illing ME, Rajan RS, Bence NF, Kopito RR. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem. 2002;277:34150-34l60.
82. Saliba RS, Munro PM, Luthert PJ, Cheetham ME. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J Cell Sci. 2002;115:2907-2918.
83. Chuang JZ, Vega C, Jun W, Sung CH. Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin-arrestin complexes. J Clin Invest. 2004;114:131-140.
84. Noorwez SM, Malhotra R, McDowell JH, et al. Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H. J Biol Chem. 2004;279:16278-16284.
85. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10:S10-S17.
86. Chapple JP, Grayson C, Hardcastle AJ, et al. Unfolding retinal dystrophies: a role for molecular chaperones? Trends Mol Med. 2001;7:414-421.
87. Li Z, Arnaud L, Rockwell P, Figueiredo-Pereira ME. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells. J Neurochem. 2004;90:19-28.
88. Grune T, Jung T, Merker K, Davies KJ. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int J Biochem Cell Biol. 2004;36:2519-2530.
89. Organisciak DT, Winkler B. Retinal light damage: practical and theoretical considerations. Prog Retin Eye Res. 1994:1-29.
90. Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000;10:524-530.
91. Hanayama R, Tanaka M, Miyasaka K, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004;304:1147-1150.
92. Savill J, Dransneld I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol. 2002;2:965-975.
93. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:14682-14687.
94. Hageman GS, Luthert PJ, Victor Chong NH, et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001; 20:705-732.
95. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001;20:385-414.
96. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411-431.
97. Ambati J, Anand A, Fernandez S, et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med. 2003;9:1390-1397.
98. Hoppeler T, Hendrickson P, Dietrich C, Remé CE. Morphology and time-course of denned photochemical lesions in the rabbit retina. Curr Eye Res. 1988;7:849-860.
99. Jung H, Remé CE. Light-evoked arachidonic acid release in the retina: illuminance/duration dependence and the effects of quinacrine, melitin and lithium. Graefes Arch Clin Exp Ophthalmol. 1994;232:167-175.
100. Reinboth JJ, Clausen M, Remé CE. Light elicits the release of docosahexaenoic acid from membrane phospholipids in the rat retina in vitro. Exp Eye Res. 1996;63:277-284.